Casdin Capital’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.7M | Buy |
1,450,000
+24,438
| +2% | +$416K | 2.25% | 11 |
|
|
2025
Q1 | $27.8M | Buy |
1,425,562
+175,562
| +14% | +$3.43M | 2.28% | 10 |
|
|
2024
Q4 | $31M | Buy |
1,250,000
+475,000
| +61% | +$11.8M | 2.06% | 12 |
|
|
2024
Q3 | $19M | Buy |
775,000
+100,000
| +15% | +$2.45M | 1.27% | 19 |
|
|
2024
Q2 | $15.8M | Hold |
675,000
| – | – | 1.21% | 19 |
|
|
2024
Q1 | $22.3M | Buy |
675,000
+147,000
| +28% | +$4.86M | 1.66% | 19 |
|
|
2023
Q4 | $14.4M | Sell |
528,000
-42,000
| -7% | -$1.14M | 1.41% | 17 |
|
|
2023
Q3 | $13.7M | Hold |
570,000
| – | – | 1.52% | 18 |
|
|
2023
Q2 | $18.2M | Hold |
570,000
| – | – | 1.59% | 22 |
|
|
2023
Q1 | $17.5M | Buy |
570,000
+200,000
| +54% | +$6.12M | 1.44% | 21 |
|
|
2022
Q4 | $14.5M | Hold |
370,000
| – | – | 1.12% | 25 |
|
|
2022
Q3 | $17.6M | Sell |
370,000
-5,000
| -1% | -$238K | 1.16% | 17 |
|
|
2022
Q2 | $14.5M | Sell |
375,000
-443,820
| -54% | -$17.2M | 1.23% | 22 |
|
|
2022
Q1 | $46.9M | Hold |
818,820
| – | – | 2.1% | 18 |
|
|
2021
Q4 | $65.3M | Hold |
818,820
| – | – | 1.84% | 19 |
|
|
2021
Q3 | $71.2M | Hold |
818,820
| – | – | 1.77% | 23 |
|
|
2021
Q2 | $105M | Hold |
818,820
| – | – | 2.68% | 14 |
|
|
2021
Q1 | $65.5M | Buy |
818,820
+358,820
| +78% | +$28.7M | 1.95% | 16 |
|
|
2020
Q4 | $37.6M | Buy |
+460,000
| New | +$37.6M | 1.11% | 25 |
|